• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses.表达共抑制分子 TIGIT 的调节性 T 细胞选择性地抑制促炎 Th1 和 Th17 细胞反应。
Immunity. 2014 Apr 17;40(4):569-81. doi: 10.1016/j.immuni.2014.02.012.
2
Clinical Remission of Sight-Threatening Non-Infectious Uveitis Is Characterized by an Upregulation of Peripheral T-Regulatory Cell Polarized Towards T-bet and TIGIT.威胁视力的非感染性葡萄膜炎的临床缓解表现为外周 T 调节细胞向 T-bet 和 TIGIT 极化的上调。
Front Immunol. 2018 May 3;9:907. doi: 10.3389/fimmu.2018.00907. eCollection 2018.
3
Suppressive IL-17AFoxp3 and ex-Th17 IL-17AFoxp3 T cells are a source of tumour-associated T cells.抑制性的 IL-17A+Foxp3+ 和前 Th17 细胞 IL-17A+Foxp3+T 细胞是肿瘤相关 T 细胞的来源。
Nat Commun. 2017 Mar 14;8:14649. doi: 10.1038/ncomms14649.
4
Phenotype analyses of IL-10-producing Foxp3 CD4 T cells increased by subcutaneous immunotherapy in allergic airway inflammation.皮下免疫治疗可增加过敏性气道炎症中产生 IL-10 的 Foxp3+CD4+T 细胞的表型分析。
Int Immunopharmacol. 2018 Aug;61:297-305. doi: 10.1016/j.intimp.2018.06.014. Epub 2018 Jun 14.
5
The regulatory T cell effector molecule fibrinogen-like protein 2 is necessary for the development of rapamycin-induced tolerance to fully MHC-mismatched murine cardiac allografts.调节性T细胞效应分子纤维蛋白原样蛋白2是雷帕霉素诱导对完全MHC不匹配的小鼠心脏同种异体移植物产生耐受性所必需的。
Immunology. 2015 Jan;144(1):91-106. doi: 10.1111/imm.12354.
6
Shenghua Decoction reduces uterine bleeding and regulates T-cell paradigm in human deciduas of RU486 medical abortion.生化汤减少 RU486 药物流产人蜕膜组织中 T 细胞范式的出血。
J Ethnopharmacol. 2013 Dec 12;150(3):907-17. doi: 10.1016/j.jep.2013.09.033. Epub 2013 Oct 17.
7
Deletion of Fibrinogen-like Protein 2 (FGL-2), a Novel CD4+ CD25+ Treg Effector Molecule, Leads to Improved Control of Echinococcus multilocularis Infection in Mice.新型CD4+ CD25+调节性T细胞效应分子纤维蛋白原样蛋白2(FGL-2)的缺失可改善小鼠对多房棘球绦虫感染的控制。
PLoS Negl Trop Dis. 2015 May 8;9(5):e0003755. doi: 10.1371/journal.pntd.0003755. eCollection 2015 May.
8
Treg expression of CIS suppresses allergic airway inflammation through antagonizing an autonomous TH2 program.CIS 对 Treg 的表达通过拮抗自主的 TH2 程序来抑制过敏性气道炎症。
Mucosal Immunol. 2020 Mar;13(2):293-302. doi: 10.1038/s41385-019-0236-3. Epub 2019 Nov 28.
9
Suppression of ongoing experimental autoimmune myasthenia gravis by transfer of RelB-silenced bone marrow dentritic cells is associated with a change from a T helper Th17/Th1 to a Th2 and FoxP3+ regulatory T-cell profile.过继转导 RelB 沉默的骨髓树突状细胞可抑制实验性自身免疫性重症肌无力,与 Th17/Th1 向 Th2 和 FoxP3+调节性 T 细胞表型的转变有关。
Inflamm Res. 2010 Mar;59(3):197-205. doi: 10.1007/s00011-009-0087-6. Epub 2009 Sep 19.
10
Divergent Phenotypes of Human Regulatory T Cells Expressing the Receptors TIGIT and CD226.表达受体TIGIT和CD226的人类调节性T细胞的不同表型
J Immunol. 2015 Jul 1;195(1):145-55. doi: 10.4049/jimmunol.1402381. Epub 2015 May 20.

引用本文的文献

1
TIGIT in cancer: from mechanism of action to promising immunotherapeutic strategies.癌症中的TIGIT:从作用机制到有前景的免疫治疗策略
Cell Death Dis. 2025 Sep 1;16(1):664. doi: 10.1038/s41419-025-07984-4.
2
The homeostasis and heterogeneity of regulatory T cells in sepsis.脓毒症中调节性T细胞的稳态与异质性
Burns Trauma. 2025 Jul 15;13:tkaf047. doi: 10.1093/burnst/tkaf047. eCollection 2025.
3
A platform for multisite immune profiling of premetastatic pancreatic cancer at single-cell resolution.一个用于在单细胞分辨率下对转移性胰腺癌进行多部位免疫分析的平台。
Cancer Immunol Immunother. 2025 Aug 23;74(9):291. doi: 10.1007/s00262-025-04146-5.
4
AIF1 Regulates the Progression of Esophageal Squamous Cell Carcinoma Through Negative Regulation of Immune T Cell Efflux Function by TIGIT Signal.AIF1通过TIGIT信号对免疫T细胞外排功能的负调控来调节食管鳞状细胞癌的进展。
Dig Dis Sci. 2025 Aug 19. doi: 10.1007/s10620-025-09331-1.
5
Pharmacological and structural characterization of vibostolimab, a novel anti-TIGIT blocking antibody for cancer immunotherapy.维博妥利单抗(vibostolimab)的药理学和结构特征,一种用于癌症免疫治疗的新型抗TIGIT阻断抗体。
J Immunother Cancer. 2025 Aug 18;13(8):e008972. doi: 10.1136/jitc-2024-008972.
6
Lymph node transcriptomic profiles suggest susceptibility to bleomycin-induced pulmonary toxicity in classic hodgkin lymphoma.淋巴结转录组图谱提示经典型霍奇金淋巴瘤对博来霉素诱导的肺毒性易感。
Sci Rep. 2025 Aug 18;15(1):30273. doi: 10.1038/s41598-025-16218-8.
7
The Multifaceted Role of Regulatory T Cells in Sepsis: Mechanisms, Heterogeneity, and Pathogen-Tailored Therapies.调节性T细胞在脓毒症中的多方面作用:机制、异质性及病原体针对性疗法
Int J Mol Sci. 2025 Aug 1;26(15):7436. doi: 10.3390/ijms26157436.
8
TIGIT, as a potential immune checkpoint target for immunotherapy of breast cancer.TIGIT作为乳腺癌免疫治疗的潜在免疫检查点靶点。
Med Oncol. 2025 Aug 5;42(9):407. doi: 10.1007/s12032-025-02955-3.
9
Generation of Regulatory T Cells From Human Memory CD4T Cells by Upregulation of Naked Cuticle Homolog 2.通过上调裸皮同源物2从人记忆性CD4 T细胞生成调节性T细胞。
Eur J Immunol. 2025 Aug;55(8):e70018. doi: 10.1002/eji.70018.
10
Dose escalation study of the HLA-A2-WT1 CD3 bispecific antibody RO7283420 in relapsed/refractory acute myeloid leukemia.HLA-A2-WT1 CD3双特异性抗体RO7283420在复发/难治性急性髓系白血病中的剂量递增研究。
Blood Neoplasia. 2025 May 11;2(3):100110. doi: 10.1016/j.bneo.2025.100110. eCollection 2025 Aug.

本文引用的文献

1
T-bet(+) Treg cells undergo abortive Th1 cell differentiation due to impaired expression of IL-12 receptor β2.T-bet(+) Treg 细胞由于 IL-12 受体 β2 表达受损而经历无效的 Th1 细胞分化。
Immunity. 2012 Sep 21;37(3):501-10. doi: 10.1016/j.immuni.2012.05.031. Epub 2012 Sep 6.
2
OX40 signaling favors the induction of T(H)9 cells and airway inflammation.OX40 信号转导有利于诱导 T(H)9 细胞和气道炎症。
Nat Immunol. 2012 Oct;13(10):981-90. doi: 10.1038/ni.2390. Epub 2012 Jul 29.
3
Resolvin D1 and aspirin-triggered resolvin D1 promote resolution of allergic airways responses.解析素 D1 和阿司匹林触发的解析素 D1 促进过敏性气道反应的消退。
J Immunol. 2012 Aug 15;189(4):1983-91. doi: 10.4049/jimmunol.1101665. Epub 2012 Jul 16.
4
PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells.过氧化物酶体增殖物激活受体-γ(PPAR-γ)是脂肪组织调节性 T 细胞(Treg 细胞)积累和表型的主要驱动因素。
Nature. 2012 Jun 28;486(7404):549-53. doi: 10.1038/nature11132.
5
Loss of epigenetic modification driven by the Foxp3 transcription factor leads to regulatory T cell insufficiency.Foxp3 转录因子驱动的表观遗传修饰缺失导致调节性 T 细胞功能不足。
Immunity. 2012 May 25;36(5):717-30. doi: 10.1016/j.immuni.2012.03.020. Epub 2012 May 10.
6
An N-terminal mutation of the Foxp3 transcription factor alleviates arthritis but exacerbates diabetes.Foxp3 转录因子的 N 端突变可缓解关节炎,但会加重糖尿病。
Immunity. 2012 May 25;36(5):731-41. doi: 10.1016/j.immuni.2012.04.007. Epub 2012 May 10.
7
The TIGIT/CD226 axis regulates human T cell function.TIGIT/CD226 轴调节人类 T 细胞功能。
J Immunol. 2012 Apr 15;188(8):3869-75. doi: 10.4049/jimmunol.1103627. Epub 2012 Mar 16.
8
Foxp3+ follicular regulatory T cells control the germinal center response.Foxp3+ 滤泡调节性 T 细胞控制生发中心反应。
Nat Med. 2011 Jul 24;17(8):975-82. doi: 10.1038/nm.2425.
9
Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions.表达 Foxp3 和 Bcl-6 的滤泡调节性 T 细胞抑制生发中心反应。
Nat Med. 2011 Jul 24;17(8):983-8. doi: 10.1038/nm.2426.
10
Vstm3 is a member of the CD28 family and an important modulator of T-cell function.VSTM3 是 CD28 家族的成员,是 T 细胞功能的重要调节剂。
Eur J Immunol. 2011 Apr;41(4):902-15. doi: 10.1002/eji.201041136. Epub 2011 Mar 18.

表达共抑制分子 TIGIT 的调节性 T 细胞选择性地抑制促炎 Th1 和 Th17 细胞反应。

Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses.

机构信息

Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Department of Neurology and Immunobiology, Yale School of Medicine, New Haven, CT 06520, USA.

出版信息

Immunity. 2014 Apr 17;40(4):569-81. doi: 10.1016/j.immuni.2014.02.012.

DOI:10.1016/j.immuni.2014.02.012
PMID:24745333
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4070748/
Abstract

Foxp3(+) T regulatory (Treg) cells regulate immune responses and maintain self-tolerance. Recent work shows that Treg cells are comprised of many subpopulations with specialized regulatory functions. Here we identified Foxp3(+) T cells expressing the coinhibitory molecule TIGIT as a distinct Treg cell subset that specifically suppresses proinflammatory T helper 1 (Th1) and Th17 cell, but not Th2 cell responses. Transcriptional profiling characterized TIGIT(+) Treg cells as an activated Treg cell subset with high expression of Treg signature genes. Ligation of TIGIT on Treg cells induced expression of the effector molecule fibrinogen-like protein 2 (Fgl2), which promoted Treg-cell-mediated suppression of T effector cell proliferation. In addition, Fgl2 was necessary to prevent suppression of Th2 cytokine production in a model of allergic airway inflammation. TIGIT expression therefore identifies a Treg cell subset that demonstrates selectivity for suppression of Th1 and Th17 cell but not Th2 cell responses.

摘要

Foxp3(+) T 调节性 (Treg) 细胞调节免疫反应并维持自身耐受。最近的工作表明,Treg 细胞由具有专门调节功能的许多亚群组成。在这里,我们鉴定出表达共抑制分子 TIGIT 的 Foxp3(+) T 细胞作为一个独特的 Treg 细胞亚群,特异性抑制促炎辅助性 T 细胞 1 (Th1) 和 Th17 细胞,但不抑制 Th2 细胞反应。转录谱特征表明 TIGIT(+) Treg 细胞是一种激活的 Treg 细胞亚群,高表达 Treg 特征基因。TIGIT 在 Treg 细胞上的配体结合诱导效应分子纤维蛋白原样蛋白 2 (Fgl2) 的表达,从而促进 Treg 细胞介导的 T 效应细胞增殖抑制。此外,Fgl2 对于防止在变应性气道炎症模型中抑制 Th2 细胞因子产生是必需的。因此,TIGIT 表达鉴定了一个 Treg 细胞亚群,其显示对 Th1 和 Th17 细胞反应的选择性抑制,但不抑制 Th2 细胞反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ccd/4070748/7cd10f0b7197/nihms-582401-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ccd/4070748/f14ee97c744e/nihms-582401-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ccd/4070748/09a5c3bcdfdc/nihms-582401-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ccd/4070748/988fbca9cf6a/nihms-582401-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ccd/4070748/3c3697d1bc0e/nihms-582401-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ccd/4070748/b1f06b6ed424/nihms-582401-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ccd/4070748/7cd10f0b7197/nihms-582401-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ccd/4070748/f14ee97c744e/nihms-582401-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ccd/4070748/09a5c3bcdfdc/nihms-582401-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ccd/4070748/988fbca9cf6a/nihms-582401-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ccd/4070748/3c3697d1bc0e/nihms-582401-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ccd/4070748/b1f06b6ed424/nihms-582401-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ccd/4070748/7cd10f0b7197/nihms-582401-f0006.jpg